chr9-78297199-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_058179.4(PSAT1):c.-12G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.78 in 1,593,282 control chromosomes in the GnomAD database, including 486,704 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.79 ( 48248 hom., cov: 34)
Exomes 𝑓: 0.78 ( 438456 hom. )
Consequence
PSAT1
NM_058179.4 5_prime_UTR
NM_058179.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.48
Genes affected
PSAT1 (HGNC:19129): (phosphoserine aminotransferase 1) This gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is a phosphoserine aminotransferase and decreased expression may be associated with schizophrenia. Mutations in this gene are also associated with phosphoserine aminotransferase deficiency. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 1, 3, and 8. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-78297199-G-C is Benign according to our data. Variant chr9-78297199-G-C is described in ClinVar as [Benign]. Clinvar id is 367450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-78297199-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.819 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSAT1 | NM_058179.4 | c.-12G>C | 5_prime_UTR_variant | 1/9 | ENST00000376588.4 | NP_478059.1 | ||
PSAT1 | NM_021154.5 | c.-12G>C | 5_prime_UTR_variant | 1/8 | NP_066977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSAT1 | ENST00000376588.4 | c.-12G>C | 5_prime_UTR_variant | 1/9 | 1 | NM_058179.4 | ENSP00000365773 | P1 | ||
PSAT1 | ENST00000347159.6 | c.-12G>C | 5_prime_UTR_variant | 1/8 | 1 | ENSP00000317606 |
Frequencies
GnomAD3 genomes AF: 0.795 AC: 120866AN: 152086Hom.: 48212 Cov.: 34
GnomAD3 genomes
AF:
AC:
120866
AN:
152086
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.785 AC: 169160AN: 215464Hom.: 66798 AF XY: 0.779 AC XY: 91924AN XY: 117966
GnomAD3 exomes
AF:
AC:
169160
AN:
215464
Hom.:
AF XY:
AC XY:
91924
AN XY:
117966
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.779 AC: 1122336AN: 1441078Hom.: 438456 Cov.: 53 AF XY: 0.777 AC XY: 556246AN XY: 716034
GnomAD4 exome
AF:
AC:
1122336
AN:
1441078
Hom.:
Cov.:
53
AF XY:
AC XY:
556246
AN XY:
716034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.795 AC: 120958AN: 152204Hom.: 48248 Cov.: 34 AF XY: 0.795 AC XY: 59181AN XY: 74428
GnomAD4 genome
AF:
AC:
120958
AN:
152204
Hom.:
Cov.:
34
AF XY:
AC XY:
59181
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2263
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
PSAT deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Oct 25, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Neu-Laxova syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Oct 25, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at